BEHZAD B SAKETKHOU

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease ATLANTIS, FL NPI 1477536217

General Payments — all program years on this page

$1,860.03

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 79
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $471.94 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $471.9416

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $123.618
2019 $259.7013
2020 $105.946
2021 $223.4811
2022 $177.399
2023 $497.9716
2024 $471.9416

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087224949 Novartis Pharmaceuticals Corporation $12.20 02/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087224963 Novartis Pharmaceuticals Corporation $22.00 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087224995 Novartis Pharmaceuticals Corporation $16.54 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087224997 Novartis Pharmaceuticals Corporation $29.80 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087225013 Novartis Pharmaceuticals Corporation $24.47 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087225015 Novartis Pharmaceuticals Corporation $27.73 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087225031 Novartis Pharmaceuticals Corporation $22.16 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087225033 Novartis Pharmaceuticals Corporation $26.21 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111695900 Amgen Inc. $13.67 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125083689 Abbott Laboratories $13.85 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125083691 Abbott Laboratories $16.51 11/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136075865 Lilly USA, LLC $125.00 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146921208 Philips North America LLC $18.46 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146921212 Philips North America LLC $30.89 06/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146921214 Philips North America LLC $46.01 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154053127 iRhythm Technologies, Inc. $26.44 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.